⚠ Regulatory caution
📰Read the full Bitter Orange evidence review on GMJ News →Complete clinical article, references and updates on news.gmj.ge. This page is the structured safety summary.⚠ Patient on MAOIs using bitter orange — sympathomimetic hypertensive crisis [1]
⚠ Patient on CYP3A4 drugs (statins, immunosuppressants) using bitter orange — furanocoumarin CYP inhibition [1]
⚠ Patient combining bitter orange + caffeine + other stimulants — most CV adverse events in this context [2]
⚠ Patient expecting significant weight loss — effect is marginal (~1–2 kg) [1]
🥗 Food first — build your daily Typical 10–50 mg synephrine
Check the foods you regularly eat — the bar fills toward your daily target.
Bitter orange marmalade (1 tbsp)5 mg p-synephrine (approximate)
Seville orange juice (100 mL)10 mg p-synephrine (approximate)
Check your regular foods above
🔬 Lab interpreter
Recommended test
Blood pressure and heart rate
Blood pressure and heart rate
Reference range / target
Normal ranges
Normal ranges
Especially important if combined with caffeine [2].
Full lab monitoring ↓⚕ For professionals — confirm ranges against your local laboratory.
Clinical verdict
Bitter orange (p-synephrine) replaced ephedra post-2004 ban. Alone at ≤50 mg/day: pharmacologically distinct from ephedrine (β-3 selective) with acceptable acute hemodynamics. COMBINED with caffeine: most adverse event reports occur in this combo. Weight-loss effect is marginal (1–2 kg). CYP3A4 inhibition (grapefruit-like furanocoumarins) is an underrecognized drug interaction [1] [2].
1 How much do I need?
👤 Adults: Specific dosage data under clinical review
👴 Elderly: Specific dosage data under clinical review
🤰 Pregnancy: See guidance
Avoid. Stimulant supplement contraindicated in pregnancy [1].
👦 Pediatric: See guidance
Not appropriate for children. Weight-loss stimulants not indicated in pediatrics [1].
🏃 Athletes: Standard dose
⚖️ Obesity: Standard dose
Fat-soluble compounds may require dose adjustment in obesity.
🩺 Renal: Consult specialist
Dose adjustment may be needed in renal impairment.
🌱 Vegan: Standard dose
How to take
🍽 Timing: Morning (stimulant effect). Before exercise if used for thermogenesis [1].
💊 With food: Can be taken with or without food [1].
2 Which form?
| Form | Bioavailability | Vegan | Cost |
|---|---|---|---|
| ['Bitter orange extract (standardized to synephrine)', 'common', 'Standardized to 6–10% p-synephrine. 10–50 mg synephrine/day [1].'] | Standard | Check label | |
| ['Fat burner / thermogenic blends', 'most common use', 'Bitter orange + caffeine + other stimulants. The combination is where safety concerns arise [2].'] | Standard | Check label | |
| ['Bitter orange peel (traditional)', 'culinary/TCM', 'Zhi Shi (immature fruit) or Zhi Ke (mature peel) in TCM for digestive complaints. Lower synephrine content [1].'] | Standard | Check label |
3 Common questions
Is bitter orange as dangerous as ephedra? ▼
At the receptor level, no. p-Synephrine is a selective β-3 agonist with minimal α-1 activity, while ephedrine activates α and β receptors broadly. However, bitter orange products are commonly combined with caffeine and other stimulants, and case reports of cardiovascular events exist for these combinations. p-Synephrine ALONE at ≤50 mg/day appears safer than ephedrine, but the typical product formulation is NOT p-synephrine alone [1] [2].
Does bitter orange help with weight loss? ▼
Modestly. Thermogenic effects increase metabolic rate by ~65–180 kcal/day (depending on co-ingredients). This translates to 1–2 kg over 6–12 weeks in small RCTs — clinically marginal. It is not a substitute for dietary and lifestyle modification [1].
Why does bitter orange inhibit CYP3A4? ▼
Bitter orange peel and juice contain furanocoumarins (6',7'-dihydroxybergamottin, bergamottin) — the same compounds found in grapefruit. These irreversibly inhibit intestinal CYP3A4, increasing blood levels of CYP3A4-metabolized drugs [1].
Is the synephrine in bitter orange the same as in nasal decongestants? ▼
No. Bitter orange contains p-synephrine (para-synephrine). Nasal decongestants contain phenylephrine, which is sometimes called m-synephrine (meta-synephrine). They are structural isomers with different receptor profiles and potencies [1].
4 Clinical evidence
Strong
p-Synephrine pharmacology: selective β-3 agonism well-characterized. Does NOT have the α-1 activity of ephedrine — different safety profile at receptor level [1]. HIGH
Moderate
Thermogenesis: p-synephrine (50 mg) increased resting metabolic rate by ~65 kcal/day in 1 acute study. Combined with caffeine + naringin: up to 180 kcal/day increase [1]. Weight loss: modest (1–2 kg over 6–12 weeks) in 2 small RCTs — clinically marginal [1]. Hemodynamic safety (alone): 2 acute studies found 50 mg p-synephrine alone did NOT significantly increase heart rate or blood pressure [1]. MODERATE
Insufficient
Long-term cardiovascular safety: no large-scale, long-term safety studies [2]. Case reports: MI, ischemic stroke, and QT prolongation reported in users of bitter orange-containing products — but almost all involved caffeine co-administration, making attribution impossible [2]. Athletic performance: 1–2 small studies with mixed results [1]. LOW
5 Safety, toxicity & adverse events
Absolute contraindications
✕ Cardiovascular disease, hypertension or arrhythmia — synephrine is a sympathomimetic
✕ Concurrent MAOIs
Relative
⚠ Combination with caffeine/stimulants — markedly raises cardiovascular risk
⚠ Potent CYP3A4 inhibitor (furanocoumarins) — raises levels of many drugs (like grapefruit)
⚠ Discontinue before surgery
🚩 Red flags
● Patient with cardiovascular disease using bitter orange + caffeine blend [2]
● Patient on MAOI therapy [1]
● Patient on statins/CYP3A4 drugs — grapefruit-like interaction [1]
6 Interactions
Drug interactions
MAO inhibitors Major
Mechanism: Synephrine is a sympathomimetic amine; MAOIs prevent breakdown [1].
Effect: Hypertensive crisis [1].
Action: CONTRAINDICATED [1].
CYP3A4 substrates Moderate
Mechanism: Furanocoumarins in bitter orange inhibit intestinal CYP3A4 (grapefruit-like) [1].
Effect: Increased drug levels [1].
Action: Same precautions as grapefruit [1].
Supplement synergies
None recommended · N/A
Bitter orange is best used alone at low dose. Multi-stimulant combinations increase risk [2].
Bitter orange is best used alone at low dose. Multi-stimulant combinations increase risk [2].
7 Regulatory
United States (FDA): Available as dietary supplement. FDA has not banned bitter orange despite safety concerns (unlike ephedra). Under ongoing monitoring [1].
Canada (Health Canada): p-Synephrine limited to 50 mg/day in NHP products [1].
WADA: p-Synephrine is NOT on the WADA prohibited list (unlike ephedrine at threshold doses) [1].
TCM: Zhi Shi/Zhi Ke have traditional use for digestive complaints (different from weight-loss supplementation) [1].
8 US supplement products
122
on-market products containing Bitter Orange (NIH DSLD)
Brands carrying Bitter Orange (49)
Click a brand to see its Bitter Orange products.
9 Frequently paired with
10 Cite this page
Vancouver: Pkhakadze G. Bitter Orange — safety profile [Internet]. Tbilisi: PHIG; 2026 [cited 2026 Oct 18]. Available from: https://supplement.ge/ingredients/bitter-orange/
APA 7th: Pkhakadze, G. (2026). Bitter Orange — Safety profile. Public Health Institute of Georgia. https://supplement.ge/ingredients/bitter-orange/
📋 Editorial information
Author: Prof. G. Pkhakadze, MD, MPH, PhD
Institution: Public Health Institute of Georgia (PHIG)
Affiliation: David Tvildiani Medical University (DTMU)
First published: January 2026
Last reviewed: 2026-05-29
Next review: April 2027
References: 4 cited sources
COI: SupplementIndex receives no funding from supplement manufacturers. All content independently authored by PHIG.
Process: Systematic literature review
📄 License & reuse
Published under Creative Commons Attribution 4.0 International (CC BY 4.0). You may share and adapt for any purpose with attribution.
Pkhakadze G. "Bitter Orange — Safety Profile." SupplementIndex, PHIG, 2026. https://supplement.ge/ingredients/bitter-orange/ CC BY 4.0.
GP
Prof. G. Pkhakadze, MD, MPH, PhD
Professor of Public Health · Head of Department, DTMU
Editor-in-Chief, Georgian Medical Journal (ISSN 3088-4322)
Chair, Public Health Institute of Georgia · UEMS Public Health Section
Educational and public health purposes. CC BY 4.0. Consult your healthcare provider before starting any supplement. Corrections: info@accreditation.ge. Publisher: PHIG